Sun Pharma to buy struggling Ranbaxy for $3.2 billion as Daiichi Sankyo retreats

Sun Pharmaceutical Industries Ltd has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd for $3.2 billion, betting it can fix factory quality glitches that plagued the current owner, Japan's Daiichi Sankyo Co, and got Ranbaxy India-made drugs barred

http://in.reuters.com/article/2014/04/07/daiichi-sankyo-ranbaxy-sunpharma-idINDEEA3600G20140407

YOU ARE BEING REDIRECTED TO THE ARTICLE
. . .
× CLOSE

PROCESSING